Jannik Helweg-Larsen

researcher

Jannik Helweg-Larsen is …
instance of (P31):
humanQ5

P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q1233624322095. Associations between Invasive Aspergillosis and Cytomegalovirus Infections in Lung Transplant Recipients
Q12313941382. Incidence rates of invasive aspergillosis among lung transplant recipients in timeperiods with universal and targeted antifungal prophylaxis - a nationwide cohort study
Q95628605A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19
Q115590311A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19
Q97559098Accelerated treatment of endocarditis-The POET II trial: Rationale and design of a randomized controlled trial
Q99237703Azole-Resistant Aspergillus fumigatus Among Danish Cystic Fibrosis Patients: Increasing Prevalence and Dominance of TR34/L98H
Q50578022Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults: a Danish prospective observational cohort study.
Q37417520Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study
Q38256219Cryptococcal rib osteomyelitis as primary and only symptom of idiopathic CD4 penia
Q24794053Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia--a case-control study.
Q35880756Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
Q114665625Disseminated fusariosis with cerebral involvement in a patient with acute myeloid leukemia: Successful outcome with intrathecal –and systemic antifungal treatment
Q38680375Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study
Q38934525ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
Q30248345ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
Q38934528ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients
Q40190647Echocardiographic findings suggestive of infective endocarditis in asymptomatic Danish injection drug users attending urban injection facilities
Q92343751Fatal chronic meningitis caused by Candida dubliniensis after liver transplantation
Q38694560Immune reconstitution syndrome presenting as probable AIDS-related lymphoma: a case report
Q33919017Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study
Q30983646Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania
Q120718499Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study
Q101560359Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis
Q35507702Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime
Q120251432Invasive procedures and risk of brain abscess: a nationwide, population-based case-control study
Q92440079Long-Term Outcomes of Partial Oral Treatment of Endocarditis
Q98195788Normocellular Community-Acquired Bacterial Meningitis in Adults: A Nationwide Population-Based Case Series
Q37305589Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii
Q63762072Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
Q80497353Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004
Q36189505Pneumocystis jiroveci. Applied molecular microbiology, epidemiology and diagnosis
Q38953280Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response
Q54534916Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.
Q34495387Pyogenic brain abscess, a 15 year survey
Q91563633Risk factors and prognosis of seizures in adults with community-acquired bacterial meningitis in Denmark: observational cohort studies
Q44572731S-adenosylmethionine in plasma to test for Pneumocystis carinii pneumonia
Q37116747Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review
Q86680029Severely elevated C-reactive protein accompanied by prolonged high fever and leukocytosis in a healthy peripheral blood stem cell donor: an atypical granulocyte-colony-stimulating factor reaction?
Q40445819Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study
Q34502836Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia
Q89901284Varicella Zoster Virus encephalitis in Denmark from 2015 to 2019- A nationwide prospective cohort study
Q54977883[Periodic fever syndromes].
Q91618856[Voriconazole-induced periostitis]

Search more.